Related Experiment Videos

Long-term antimicrobial therapy in the prevention of recurrent soft-tissue infections

M Kremer1, R Zuckerman, Z Avraham

  • 1Department of Dermatology, Zvulum Outpatient Clinic, Kyriat Motzkin, Israel.

The Journal of Infection
|January 1, 1991
PubMed

Insights

Preventing recurrent skin infections like erysipelas and cellulitis is possible with long-term antibiotic prophylaxis. A study showed erythromycin prevented infections in patients with a history of recurrent soft-tissue infections.

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Pharmacology

Background:

  • Recurrent erysipelas and cellulitis pose significant health challenges.
  • Previous infections increase the risk of subsequent episodes.

Purpose of the Study:

  • To evaluate the efficacy and safety of prolonged antimicrobial prophylaxis in preventing recurrent soft-tissue infections.
  • To assess the effectiveness of erythromycin in patients with a history of recurrent erysipelas or cellulitis.

Main Methods:

  • A randomized controlled trial involving 36 patients with a history of two or more erysipelas/cellulitis episodes in the prior year.
  • Patients were divided into two groups: one received erythromycin base 250 mg twice daily for 18 months, while the control group received no prophylaxis.
  • Follow-up was conducted for 18 months to monitor for infection recurrence.

Main Results:

  • None of the patients in the erythromycin prophylaxis group experienced a recurrence of infection.
  • Eight patients (50%) in the control group relapsed and required antibiotic treatment.
  • Erythromycin prophylaxis demonstrated a 100% prevention rate for recurrent soft-tissue infections in this cohort.

Conclusions:

  • Prolonged antimicrobial prophylaxis, specifically with erythromycin, is highly effective in preventing recurrent episodes of erysipelas and cellulitis.
  • The prophylactic regimen was found to be safe, with no infections reported in the treated group.
  • Long-term antibiotic use is a viable strategy for managing patients prone to recurrent soft-tissue infections.

Related Concept Videos